We are live on ! Find out more
SYRE icon

Spyre Therapeutics

Name Holding Trade Value Shares
Change
Change in
Stake
O
1
OrbiMed
New York
$31.8M
BBA
2
Baker Bros. Advisors
New York
$27M
BlackRock
3
BlackRock
New York
$26.5M +$847K +4,413 +3%
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$23.3M -$337K -1,754 -1%
BCLSI
5
Bain Capital Life Sciences Investors
Massachusetts
$21.4M
PAMU
6
Pictet Asset Management (UK)
United Kingdom
$20M
Vanguard Group
7
Vanguard Group
Pennsylvania
$17.2M +$1.71M +8,913 +11%
NCM
8
Nantahala Capital Management
Connecticut
$13.6M -$2.01M -10,488 -13%
ACM
9
Aisling Capital Management
New York
$13.4M
RSCM
10
Rock Springs Capital Management
Maryland
$12.5M -$20.7K -108 -0.2%
Point72 Asset Management
11
Point72 Asset Management
Connecticut
$11.9M -$10.9M -56,822 -49%
SCM
12
Suvretta Capital Management
New York
$10.8M +$4.67M +24,333 +80%
Marshall Wace
13
Marshall Wace
United Kingdom
$9.44M -$399K -2,080 -4%
Goldman Sachs
14
Goldman Sachs
New York
$9M +$5.39M +28,078 +161%
AG
15
Artal Group
Luxembourg
$8.28M
SB
16
Samsara BioCapital
California
$7M
State Street
17
State Street
Massachusetts
$5.69M -$67.9K -354 -1%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$5.21M +$697K +3,634 +16%
Dimensional Fund Advisors
19
Dimensional Fund Advisors
Texas
$4.69M +$410K +2,135 +10%
BC
20
Boxer Capital
California
$4.36M
GPP
21
Great Point Partners
Connecticut
$3.98M +$3.86M +20,116 New
Northern Trust
22
Northern Trust
Illinois
$3.57M -$224K -1,170 -6%
Axa
23
Axa
France
$3.36M +$76.2K +397 +2%
SCM
24
Sio Capital Management
New York
$3.19M +$1.62M +8,462 +111%
Millennium Management
25
Millennium Management
New York
$2.94M -$676K -3,521 -19%